Category: Covid-19
-
Communicable disease threats report, 30 July – 5 August 2023, week 31
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 30 July – 5 August 2023 and includes updates on avian influenza, botulism, echovirus, West Nile virus, COVID-19, and Crimean-Congo haemorrhagic fever.
-
Communicable disease threats report, 23-29 July 2023, week 30
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 23-29 July 2023 and includes updates on cholera, MERS-CoV, Chikungunya, dengue, COVID-19, West Nile virus, avian influenza, echovirus, botulism, and bacterial meningitis.
-
Communicable disease threats report, 16-22 July 2023, week 29
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 16-22 July 2023 and includes updates on avian influenza, Echovirus 11, COVID-19, West Nile virus, poliomyelitis, and botulism.
-
Communicable disease threats report, 9-15 July 2023, week 28
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 9-15 July 2023 and includes updates on avian influenza, West Nile virus, COVID-19, diphtheria, and vibrio.
-
SARS-CoV-2 variant mutations conferring reduced susceptibility to antiviral drugs and monoclonal antibodies: a non-systematic literature review for surveillance purposes
Antiviral drugs and monoclonal antibodies (mAbs), administered either separately or as combination therapy ‘cocktails’, have provided a valuable tool for fighting COVID-19. Surveillance data, coupled with data on antiviral treatment susceptibility, can guide clinical decisions on selecting the best therapy for the patient.
-
Communicable disease threats report, 2-8 July 2023, week 27
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 2-8 July 2023 and includes updates on avian influenza in domestic cats, pride celebrations, diphtheria, COVID-19, West Nile virus, mass gatherings, measles, Middle East respiratory syndrome coronavirus (MERS-CoV), Mpox, and Ralstonia mannitolilytica in dialysis patients.
-
Generic protocol for COVID-19 vaccine effectiveness in preventing transmission of infection in healthcare settings
The aim of the study protocol is to measure product-specific COVID-19 vaccine effectiveness to prevent transmission of SARS-CoV-2 infection from healthcare workers to their contacts, which can be either other patients or healthcare workers, in healthcare settings.
-
Communicable disease threats report, 25 June -1 July 2023, week 26
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 25 June – 1 July 2023. It includes updates on avian influenza, COVID-19, West Nile virus, poliomyelitis, cholera, fungal meningitis, Oz virus, and information on mass gatherings (the Hajj).
-
ECDC and EASA formally retire joint Aviation Health Safety Protocol (AHSP)
The European Union Aviation Safety Agency (EASA) and the European Centre for Disease Prevention and Control (ECDC) have decided to formally retire the EASA-ECDC joint Aviation Health Safety Protocol (AHSP), while acknowledging its significant value during the high SARS-CoV-2 circulation periods during the pandemic.
-
Communicable disease threats report, 18-24 June 2023, week 25
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 18-24 June 2023 and includes updates on swine influenza, COVID-19, West Nile virus, mass gatherings and gonorrhoea.